Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia

Journal of Cystic Fibrosis

Volumn 14, Issue 1, 2015, Pages 46-52

  Qvist, Tavs ^a,i   Gilljam, Marita ^b,i   Jönsson, Bodil ^b,i   Taylor Robinson, David ^c   Jensen Fangel, Søren ^d,i   Wang, Mikala ^d,i   Svahn, Anita ^e   Kötz, Karsten ^b,i   Hansson, Lennart ^f,i   Hollsing, Annika ^g,i   Hansen, Christine R ^a,i   Finstad, Pål L ^h,i   Pressler, Tania ^a,i   Høiby, Niels ^a,i   Katzenstein, Terese L ^a,i   Bakkeheim, Egil ⁱ   Skrede, Bjørn ⁱ   Storrøsten, Olav Trond ⁱ   Hermansen, Nils Olav ⁱ   Lærum, Birger N ⁱ   Lindblad, Anders ⁱ   Ericsson, Petrea ⁱ   Hjelte, Lena ⁱ   Karpati, Ferenc ⁱ   Krjukova, Jelena ⁱ   de Monesttrol, Isabelle ⁱ   Elidottir, Helga ⁱ   Sturegard, Erik ⁱ   Lindberg, Ulrika ⁱ   Kämpe, Mary ⁱ   Pincikova, Terezia ⁱ   Olesen, Hanne Vebert ⁱ   Schiøtz, Peter Oluf ⁱ   Petersen, Jørgen Eskild ⁱ   Skov, Marianne ⁱ   Kongstad, Thomas ⁱ   Green, Kent ⁱ   Nielsen, Kim G ⁱ   Johansen, Helle Krogh ⁱ   Mared, Lena ⁱ   more..

^a Rigshospitalet   (Denmark)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ Oslo University Hospital ^*  (Denmark)

Author keywords

Mycobacterium abscessus; Mycobacterium avium; Prevalence; Susceptibility

Indexed keywords

AZITHROMYCIN; STEROID;

ADOLESCENT; ADULT; ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIUM CULTURE; CHILD; CYSTIC FIBROSIS; DATA BASE; DENMARK; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; NONHUMAN; NORWAY; OBSERVATIONAL STUDY; PANCREAS INSUFFICIENCY; PREVALENCE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SCANDINAVIA; SPUTUM CULTURE; SWEDEN; AGE DISTRIBUTION; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; SEVERITY OF ILLNESS INDEX; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COHORT STUDIES; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE; RETROSPECTIVE STUDIES; SCANDINAVIAN AND NORDIC COUNTRIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84918560410     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.08.002     Document Type: Article

References (33)

1. Leung J.M., Olivier K.N. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. Curr Opin Pulm Med 2013, 19:662-669.
2. Martiniano S.L., Sontag M.K., Daley C.L., Nick J.A., Sagel S.D. Clinical significance of a first positive nontuberculous mycobacterial culture in cystic fibrosis. Ann Am Thorac Soc 2014, 11:36-44.
3. Qvist T., Pressler T., Høiby N., Katzenstein T.L. Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis. Respir Res 2014, 15:41.
4. Griffith D.E. Therapy of nontuberculous mycobacterial disease. Curr Opin Infect Dis 2007, 20:198-203.
5. Ballarino G.J., Olivier K.N., Claypool R.J., Holland S.M., Prevots D.R. Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. Respir Med 2009, 103:1448-1455.
6. Bryant J.M., Grogono D.M., Greaves D., Foweraker J., Roddick I., Inns T., et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 2013, 381:1551-1560.
7. CIA The World Factbook [Accessed April 28th 2014, n.d.]. http://Https//www.cia.gov/library/publications/the-World-Factbook/.
8. World Health Organization WHO Genomics [accessed April 28th 2014]. http://http//www.who.int/genomics/public/geneticdiseases/en/index2.html#CF.
9. Lannefors L., Lindgren A. Demographic transition of the Swedish cystic fibrosis community - results of modern care. Respir Med 2002, 96:681-685.
10. Knudsen P.K., Olesen H.V., Høiby N., Johannesson M., Karpati F., Laerum B.N., et al. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cyst Fibros 2009, 8:135-142.
11. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
12. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18years of age. Pediatr Pulmonol 1993, 15:75-88.
13. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159:179-187.
14. Esther C.R., Hoberman S., Fine J., Allen S., Culbreath K., Rodino K., et al. Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis. J Clin Microbiol 2011, 49:1421-1425.
15. Mäkinen J., Sarkola A., Marjamäki M., Viljanen M.K., Soini H. Evaluation of genotype and LiPA MYCOBACTERIA assays for identification of Finnish mycobacterial isolates. J Clin Microbiol 2002, 40:3478-3481.
16. Brunello F., Ligozzi M., Cristelli E., Bonora S., Tortoli E., Fontana R. Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene. J Clin Microbiol 2001, 39:2799-2806.
17. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
18. Pincikova T., Nilsson K., Moen I.E., Fluge G., Hollsing A., Knudsen P.K., et al. Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study. Diabetologia 2011, 54:3007-3015.
19. Leao S.C., Tortoli E., Viana-Niero C., Ueki S.Y.M., Lima K.V.B., Lopes M.L., et al. Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the Mycobacterium chelonae-M. abscessus group is needed. J Clin Microbiol 2009, 47:2691-2698.
20. Catherinot E., Roux A.L., Vibet M.A., Bellis G., Ravilly S., Lemonnier L., et al. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros 2013, 12:74-80.
21. Hjelte L., Petrini B., Källenius G., Strandvik B., Kallenius G. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax 1990, 45:397-400.
22. Hjelt K., Hojlyng N., Howitz P., Illum N., Munk E., Valerius N.H., et al. The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis. Scand J Infect Dis 1994, 26:569-576.
23. Marras T.K., Daley C.L. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002, 23:553-567.
24. Scarparo C., Piccoli P., Rigon A., Ruggiero G., Ricordi P., Piersimoni C. Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460TB for detection and recovery of mycobacteria from clinical specimens. Diagn Microbiol Infect Dis 2002, 44:157-161.
25. Leitritz L., Schubert S., Bücherl B., Masch A., Heesemann J., Roggenkamp A. Evaluation of BACTEC MGIT 960 and BACTEC 460TB systems for recovery of mycobacteria from clinical specimens of a university hospital with low incidence of tuberculosis. J Clin Microbiol 2001, 39:3764-3767.
26. Esther C.R., Esserman D.A., Gilligan P., Kerr A., Noone P.G., Esther C.R. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 2010, 9:117-123.
27. Renna M., Schaffner C., Brown K., Shang S., Tamayo M.H., Hegyi K., et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest 2011, 121:3554-3563.
28. Binder A.M., Adjemian J., Olivier K.N., Prevots D.R. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med 2013, 188:807-812.
29. Levy I., Grisaru-Soen G., Lerner-Geva L., Kerem E., Blau H., Bentur L., et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 2008, 14:378-384.
30. Esther C.R., Henry M.M., Molina P.L., Leigh M.W. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 2005, 40:39-44.
31. Catherinot E., Clarissou J., Etienne G., Ripoll F., Emile J.-F.F., Daffé M., et al. Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. Infect Immun 2007, 75:1055-1058.
32. Jonsson B.E., Gilljam M., Lindblad A., Ridell M., Wold A.E., Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol 2007, 45:1497-1504.
33. Mastella G., Rainisio M., Harms H.K., Hodson M.E., Koch C., Navarro J., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000, 16:464-471.